SteelPeak Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
SteelPeak Wealth's BMY Position: Q2 2026 in Review
SteelPeak Wealth increased its Bristol-Myers Squibb (BMY) stake by 80% in Q2 2026, buying an estimated $1.23M and bringing the position to 48,151 shares worth $2.77M. The position accounts for 0.07% of the portfolio, ranked #194.
SteelPeak Wealth first reported a position in BMY in Q4 2019 and has held it in 18 quarters since. The position peaked at $10.6M in Q1 2025. 885 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- SteelPeak Wealth held 48,151 shares of Bristol-Myers Squibb worth $2.77M as of Q2 2026.
- SteelPeak Wealth bought 21,442 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.23M.
- Bristol-Myers Squibb made up 0.07% of SteelPeak Wealth's portfolio in Q2 2026, its #194 holding.
- SteelPeak Wealth first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 18 quarters since.
- SteelPeak Wealth's Bristol-Myers Squibb position peaked at $10.6M in Q1 2025.
- 885 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.